Autophagy modulation in lymphocytes from COVID-19 patients: new therapeutic target in SARS-COV-2 infection M Vomero, C Barbati, T Colasanti, AI Celia, M Speziali, FM Ucci, ... Frontiers in Pharmacology 11, 569849, 2020 | 14 | 2020 |
Tofacitinib decreases autophagy of fibroblast-like synoviocytes from rheumatoid arthritis patients M Vomero, M Caliste, C Barbati, M Speziali, AI Celia, F Ucci, ... Frontiers in Pharmacology 13, 852802, 2022 | 11 | 2022 |
Application of machine learning models in systemic lupus erythematosus F Ceccarelli, F Natalucci, L Picciariello, C Ciancarella, G Dolcini, ... International Journal of Molecular Sciences 24 (5), 4514, 2023 | 8 | 2023 |
Autophagy hijacking in PBMC from COVID-19 patients results in lymphopenia C Barbati, AI Celia, T Colasanti, M Vomero, M Speziali, E Putro, ... Frontiers in Immunology 13, 903498, 2022 | 5 | 2022 |
Antinuclear antibodies may predict the development of immune-related adverse events in asymptomatic patients treated with immune checkpoint inhibitors: results from a single … F Ceccarelli, F Natalucci, L Picciariello, A Cirillo, G Olivieri, M Veroli, ... Clinical and Experimental Medicine 24 (1), 72, 2024 | | 2024 |
Are tattoos safe in patients with Systemic Lupus Erythematosus? Results from a single-centre study N Francesco, F Ceccarelli, L Picciariello, G Olivieri, C Ciancarella, ... | | 2023 |
AB0590 CROSS-SECTIONAL ASSESSMENT OF THE QUALITY OF LIFE IN SLE PATIENTS: ROLE OF DISEASE ACTIVITY, CHRONIC DAMAGE, FIBROMYALGIA SYNDROME AND MOOD DISORDERS F Natalucci, F Ceccarelli, C Massari, C Pirone, G Olivieri, V Orefice, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 1495-1495, 2023 | | 2023 |
POS0337 CHARACTERIZATION OF CIRCULATING CHONDROPROGENITOR CELLS IN PATIENTS AFFECTED BY OSTEOARTHRITIS G Buoncuore, C Barbati, E Balbinot, C Ciancarella, AI Celia, FM Ucci, ... Annals of the Rheumatic Diseases 82 (Suppl 1), 415-415, 2023 | | 2023 |
POS0410 THE ROLE OF IL-6 IN ENDOTHELIAL DYSFUNCTION: RHEUMATOID ARTHRITIS AND COVID-19, TWO PATHOGENIC MODELS IN COMPARISON AI Celia, C Barbati, T Colasanti, M Speziali, G Pellegrino, F Natalucci, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 460-461, 2022 | | 2022 |
POS0553 NEW BIOMARKERS IN RHEUMATOID ARTHRITIS: ROLE OF HOMOCYSTEINYLATED ANTI-ALPHA1 ANTITRYPSIN ANTIBODIES M Speziali, F Ceccarelli, F Natalucci, AI Celia, T Colasanti, C Barbati, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 541-541, 2022 | | 2022 |
POS0428 PATHOGENETIC ROLE OF MICROPARTICLES IN RHEUMATOID ARTHRITIS FM Ucci, C Barbati, T Colasanti, E Balbinot, M Speziali, AI Celia, ... Annals of the Rheumatic Diseases 81 (Suppl 1), 468-469, 2022 | | 2022 |
AB0087 AUTOANTIBODIES DIRECTED AGAINST HOMOCYSTEINYLATED ALPHA 1 ANTITRYPSIN AS A POTENTIAL NEW BIOMARKER FOR ARTHRITIS IN PATIENTS AFFECTED BY SYSTEMIC LUPUS ERYTHEMATOSUS F Natalucci, F Ceccarelli, T Colasanti, G Olivieri, AI Celia, C Barbati, ... Annals of the Rheumatic Diseases 80 (Suppl 1), 1073-1073, 2021 | | 2021 |